Wei Ming Li
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Hepatology 73
- Hepatocellular Carcinoma Treatment and Prognosis 41
- Hepatitis C virus research 25
- Immunology 88
- Immune Cell Function and Interaction 42
- T-cell and B-cell Immunology 16
- Co-authors
- Daniel L. Mueller (1 shared paper)Anna Mondino (1 shared paper)Christoph Kellendonk (1 shared paper)Valeria Poli (1 shared paper)Rebecca A. Taub (1 shared paper)Xianping Liang (1 shared paper)Robert P. Hebbel (1 shared paper)Smita A. Kshirsagar (1 shared paper)
- Journals
- Scientific Reports (17 papers)PLoS ONE (12 papers)Medicine (8 papers)Biochemical and Biophysical Research Communications (7 papers)Frontiers in Neurology (7 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Wei Ming Li
621 papers receiving 13.7k citations
Wei Ming Li's Hit Papers
Peers
Comparison fields: 5 of 206
- Molecular Medicine 1.3k
- Hepatology 1.2k
- Virology 439
- Immunology 1.9k
- Infectious Diseases 1.4k
Countries citing papers authored by Wei Ming Li
This map shows the geographic impact of Wei Ming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Ming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Ming Li more than expected).
Fields of papers citing papers by Wei Ming Li
This network shows the impact of papers produced by Wei Ming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Ming Li. The network helps show where Wei Ming Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Ming Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 654 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 400 | |
| 2 | Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network Hit paper breakdown → | 2017 | 362 |
| 3 | 1999 | 352 | |
| 4 | 2018 | 305 | |
| 5 | 2002 | 278 | |
| 6 | 2013 | 261 | |
| 7 | 2011 | 259 | |
| 8 | 2020 | 228 | |
| 9 | 2004 | 201 | |
| 10 | 2019 | 191 | |
| 11 | 2013 | 157 | |
| 12 | 2008 | 155 | |
| 13 | 2012 | 146 | |
| 14 | 2019 | 144 | |
| 15 | 2019 | 139 | |
| 16 | 2001 | 137 | |
| 17 | 2019 | 130 | |
| 18 | 2018 | 128 | |
| 19 | 2010 | 126 | |
| 20 | 2018 | 126 |
About Wei Ming Li
Wei Ming Li is a scholar working on Hepatology, Immunology, Oncology, Epidemiology and Virology, having authored 654 papers that have together received 14.0k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (42 papers), Hepatocellular Carcinoma Treatment and Prognosis (41 papers), Hepatitis B Virus Studies (29 papers), HIV Research and Treatment (27 papers), Hepatitis C virus research (25 papers), T-cell and B-cell Immunology (16 papers), Antibiotic Resistance in Bacteria (16 papers) and Peptidase Inhibition and Analysis (15 papers). The work is most often cited by research in Molecular Medicine (1.3k citations), Hepatology (1.2k citations), Virology (439 citations), Immunology (1.9k citations) and Infectious Diseases (1.4k citations). Wei Ming Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Daniel L. Mueller, Anna Mondino, Christoph Kellendonk, Valeria Poli, Rebecca A. Taub, Xianping Liang, Robert P. Hebbel, Smita A. Kshirsagar, Pankaj Kumar Gupta and Sundaram Ramakrishnan. Their work appears in journals such as Scientific Reports, PLoS ONE, Medicine, Biochemical and Biophysical Research Communications and Frontiers in Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.